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ABSTRACT : Fifteen patients with recurrence after surgery for lung cancer were 
clinically investigated in terms of the validity and the indication of reoperation. 
1) In most of cases with reoperation for recurrence, the disease stage was stage I lung 
cancer at the time of the initial operation. 
2) In five out of the eight patients who underwent node dissection, nodal involvement 
was positive (62.5%). 
3) A longer survivor is predicted in patients with negative node metastasis at the initial 
and the second operations. 
4) Reoperation for recurrence is required for obtaining a longer survivor, if possible. 
 The surgical outcome for lung cancer has been more and more improved. However, 
a five year survival rate is not satisfactoried with as large as 25 to 35%. It is great concern 
about the treatment of postoperative recurrence. Recently advances in the adjuvant 
therapy of chemotherapy and radiation enabled us to make the survival rate longer. 
 In rare cases with localized recurrence, it has become possible to perform a radical 
excision for recurrence. The purpose of this study is to clarity the feasibility and validity 
of reoperation on the basis of clinical experience with the 15 patients who underwent 
re-excision for recurrence.
         PATIENTS 
 Fifteen patients who underwent re-operation 
for postoperative recurrence of lung cancer were 
eligible for this study. Ten were male, five were 
female. The ages ranged from 46 to 79 years 
old with an average of 61.3 years old. The 
frequency of operations was a total of 20, that 
is, the second operation in 11, the third operation 
in three and the forth operation in one 
respectively. 
 The operation methods were listed in Table 
1. Lobectomy was used for the first operative 
method. Thereafter, a limited operation was 
selected to preserve healthy lung tissues. A few 
cases had the third and forth operation. These 
sequential surgical procedures were of benifit
to elongate the survival time. Three patients 
out of the four patients who underwent the third 
and the forth operation survived over five years. 
The other one patient survived four years as 
shown in Figure 1. 
 The shorter the interval between the initial 
and the second operations, the worse the 
surgical outocms in Case 13 and Case 15 as 
shown in Figure 1. 
 At the second operation, node dissection was 
performed in eight out of the 15 patients as 
shown in Table 2. Nodal involvement which was 
extending into the two areas of nodes(n2) was 
seen in five out of the eight patients who 
underwent nodal dissection. 
 In general, the prognoses of the patients with 
nodal involvement were poor as shown in Case 
5, 10, 11, 13 and 15 in Figure 1.
                              Table 1. Reoperative methods 
 Case No 1st OPE 2nd OPE 3rd OPE 4th OPE 
1. (49. M) LUL R S2 wedge R S1 wedge 
2. (51. F) LLL R S9 wedge RLL 
3. (67. F) RLL R S2 wedge 
4. (52. M) LUL LLL (pneumo) 
5. (56. M) RUL L S9+10 seg R Lower wedge 
6. (59. F) R S8 seg L S4 wedge R S5 wedge R S6, LS6 wedge 
7. (79. M) RUL. sleeve L S6 wedge 
8. (65. F) RLL R S2 wedge 
9. (69. M) LUL LLL (pneumo) 
10. (59. M) RLL L S1+2 seg 
11. (71. M) RLL LLL 
12. (60. M) LUL. sleeve LLL 
13. (53. F) LUL RUL 
14. (63. M) RLL L 53 wedge 
15. (70. M) LUL RML 
            * age : 2nd ope
  Table 2. Nodal involvement at reoperation 
Case NO 2nd OPE 3rd OPE 4th OPE 
1. (49. M) / / 
2. (51. F) / / 
3. (67. F) / 
4. (52. M) / 
5. (56. M) n2 / 
6. (59. F) n0 / / 
7. (79. M) / 
8. (65. F) / 
9. (69. M) n0 
10. (59. M) n2 
11. (71. M) n2 
12. (60. M) / 
13. (53. F) n2 
14. (63. M) n0 
15. (70.lvi) n2
 The disease stages in the initial operation were 
shown in Table 3. All except two were stage 
I. According to histologic types, adenocarci-
noma was in 12 and squamous cell carcinoma 
was in the other three. Nodal involvement 
extending to two areas(n2) in the two patiens 
was a main factor of progression in the disease 
stage as shown in Table 3. It is needed for early 
cancer to make the survival time longer by 
means of repeated operations. 
 Changes in lung function of %VC and 
FEV1.0% were compared between prior to and 
after operations. The values of %VC were 
appearently reduced although the values 
of %FEV,.o were not so fluctuated as shown in
                  Table 3. Disease stages at initial op. 
CASE NO TNM STAGE 1st OPE PATHO 
1. (47. M) T2NoMo I LUL adeno, well, n0 
2. (46. F) T,NoMo I LLL adeno, well, n0 
3. (62. F) T,NoMo I RLL adeno, well, nO 
4. (52. M) T,NoMo I LUL adeno, mod, nO 
5. (54. M) T,NoMo I RUL adeno, mod, nO 
6. (58. F) T,NoMo I R S8 seg adeno, well, nO 
7. (77. M) T3NoMo III RUL, slleve sq, mod, n2 
8. (55. F) T,NoMo I RLL adeno, well, nO 
9. (58. M) T,NoMo I LUL sq, well, nO 
10. (46. M) T,NoMo I RLL adeno, well, nO 
11. (69. M) T2NoMo I RLL adeno, well, nO 
12. (57. M) T,NoMo I LUL, slleve sq, well, n0 
13. (53. F) T2NoMo III LUL adeno, poor, n2 
14. (59. M) T2NoMo I RLL adeno, mod, nO 
15. (69. M) T2NoMo I LUL adeno, poor, nO
Fig. 1. Prognosis after reoperation
Fig. 2. %VC and FEV,.o%
Figure 2. 
 Postoperative survival curves were indicated 
in Figure 3 in comparison with the time from 
the initial and the repeated operations. It was
obviously showed that the survival time over 
five years was improved by the repeatd 
reoperations.
Fig. 3. Survival curve in patients with reoperation
         DISCUSSION 
 The surgical outcome for lung cancer was not 
necessarily satisfied even if lung cancers of 
stage I were operated upon. Williams'~ reported 
that a five year survival rate in stage I lung 
cancer was 56% although a three year survival 
rate was 70%. In general, a three year survival 
rate in stage I lung cancers is favorable2). In 
contrast, a five year survival rate has become 
worse. It is a reflection that complete cure from 
cancer could not be achieved even in stage I lung 
cancer. 
Immerman3) reported in patients with surgery 
for stage I and II lung cancer that most common 
sites of local recurrences were the ispilateral 
thoracic cavity, supraclaviclular and media-
stinal nodes, and also the incidence of recur-
rence in TiNo patients was 13%, that in T2No 
10.5 %, that in TiN1 and T2N, 41% respectively. 
 According to histologic types, adenocarci-
nomas more frequently occur recurrence rather 
than squamous cell carcinoma. 
 It is characteristic of squamous cell carci-
noma that high possibility of resection is 
predicted only for localized recurrence even in 
advanced cancer. 
 In this series, surgery for recurrence was 
mostly indicated for patients with stage I lung 
cancer at the time of the inital operation. The 
prognosis of the second operation in closely
associated with the presence of nodal involve-
ment. 
 In fact, reoperation is of great value to make 
the survival time of recurrent patients longer. 
Surgeons should pay an attention to high 
frequency of multicentric cancers'). 
 The diagnostic criteria are not made clear as 
to whether asynchronous cancer is metastatic 
or double cancers') when histology is almost the 
same. 
 As far as the histologic type of the second 
tumor is similar to that of the initial tumor, it 
is difficult to distinguish. Physicians should pay 
attention to the presence of recurrence if the 
tumor is solitary and is disregarded as the 
tumor metastasized from other organs. Fairly 
surgical result would be predicted by complete 
resection. 
 However, the existance of nodal involvement 
is one of the major factors which affects 
long-term survival. 
 Surgeons should attempt to eracidate the 
tumor to obtain better outcome, whenever 
possible. 
 Neptune') reported that two patients out of 
15 who underwent reoperation survived more 
than five years and Gabler') stated that two 
patients out of 17 with reoperation for re-
currence survived, over five years. Jensik8) also 
emphasized that segmentectomy for recurence 
is advisable not only for anticipation of life span 
but also for preservaiton of pulmonary function.
 In this series, the surgical outcome for re-
currence encourages surgeons to try to do with 
aggressive attitude.
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